Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial
- Resource Type
- Article
- Source
- In
The Lancet Gastroenterology & Hepatology December 2023 8(12):1118-1128 - Subject
Primary Research Articles - Language
- ISSN
- 2468-1253